A PROGNOSTIC CONTRIBUTION OF BIDIMENSIONAL LEFT ATRIAL STRAIN IN PATIENTS WITH ASYMPTOMATIC MITRAL STENOSIS
ABOUT A TUNISIAN POPULATION
Abstract
Background:
The two-dimensional strain is an objective echocardiographic technique allowing the quantification of myocardial deformation. The aim of this study was to specify prognostic contribution of left atrial strain in patients with asymptomatic mitral stenosis.
Methods:
We included consecutive patients followed for severe or moderately severe rheumatic Mitral Stenosis (MS), asymptomatic, during the period from January 2015 to June 2020 in military hospital of Tunis. The patients followed were divided into two groups according to one criterion of judgment composed of: Cardiac mortality, The occurrence of hospitalization for cardiac reasons, The occurrence of atrial fibrillation (AF), The occurrence of a thromboembolic event and the need for cardiac surgery or mitral valvuloplasty.
Results:
Initially eighteen patients were selected but only 53 were followed and then divided into two groups: 30 patients had at least one event and 23 patients had no event according to the occurrence of the major endpoint of the study. In a univariate study and for conventional echocardiographic parameters, we determined that if Left Atrium Area (LAA) is larger than 30 cm2 and left atrium volume (LAV) more than 100ml/m2, the risk of occurrence of an event increased respectively significantly (LAA: 69% vs 10%; p = 0.01; OR = 6.6; 95% CI [1.5-28]) and (LAV: 71,4% vs 39%; p = 0.002; OR = 4; 95% CI [1,1-13]). The same for left atrium deformation parameters, both Peak Atrial Longitudinal Strain (PALS) <25% and Peak Atrial Contraction Strain (PACS) <10 % were predictive of events in univariate study with these following respective odds ratios (ORs) (PALS: 83% vs 30.4%; p = 0.0001; OR = 11.4; 95% CI [3-42]), and (PACS: 90% vs 47%; p = 0.001; OR = 9.8; 95% CI [2.3-41]).In a multivariate study, the only independent parameter of the occurrence of an event was PACS <10% (p = 0.013; OR = 44; 95% CI [2.19-80]).
Conclusion:
PACS have prognostic value in asymptomatic MS as it predicts occurring of pathologic events in the following of patients with asymptomatic
References
1. Najih H, Arous S, Laarje A, Baghdadi D, Benouna MG, Azzouzi L, et al. Discordance gradient-surface dans le rétrécissement mitral: le gradient moyen transmitral est-il un critère de sévérité ou un indice de tolérance du rétrécissement mitral serré? Pan Afr Med J. 2016 ;25.
2. Caso P, Ancona R, Di Salvo G, Comenale Pinto S, Macrino M, Di Palma V, et al. Atrial reservoir function by strain rate imaging in asymptomatic mitral stenosis: prognostic value at 3 year follow-up. Eur J Echocardiogr. 2009;10(6):753‑9.
3. Ancona R, Comenale Pinto S, Caso P, Di Salvo G, Severino S, D’Andrea A, et al. Two-Dimensional Atrial Systolic Strain Imaging Predicts Atrial Fibrillation at 4-Year Follow-Up in Asymptomatic Rheumatic Mitral Stenosis. J Am Soc Echocardiogr. 2013;26(3):270‑7.
4. Magdy M. El-Masry MD, Mona a. El-Saedy MD. Left Atrial Function Assessment in Patients with Rheumatic Mitral Valve Diseases. Med J Cairo Univ. 2019;87:769‑80.
5. N K. ASSESSMENT OF LEFT ATRIAL FUNCTION IN PATIENTS WITHMITRAL VALVE DISEASES. Asian J Pharm Clin Res. 2016;9(6):334.
6. Moise B, Rosca M, Alexandru D, Ginghina C. Left atrial remodelling in patients with mitral stenosis. 2017;27(2):7.
7. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231‑43.
8. Inaba Y, Yuda S, Kobayashi N, Hashimoto A, Uno K, Nakata T, et al. Strain rate imaging for noninvasive functional quantification of the left atrium: comparative studies in controls and patients with atrial fibrillation. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2005;18(7):729‑36.
9. Ae M, Ac W, R D, C S, Jb K, F O, et al. Factors associated with atrial fibrillation in patients with mitral stenosis: a cardiac catheterization study. Am Heart J. 1998;135(1):138‑45.
10. Selzer A. Effects of atrial fibrillation upon the circulation in patients with mitral stenosis. Am Heart J. 1960;59:518‑26.
11. Unverferth DV, Fertel RH, Unverferth BJ, Leier CV. Atrial fibrillation in mitral stenosis: histologic, hemodynamic and metabolic factors. Int J Cardiol. 1984;5(2):143‑54.
12. Her AY, Choi EY, Shim CY, Song BW, Lee S, Ha JW, et al. Prediction of Left Atrial Fibrosis With Speckle Tracking Echocardiography in Mitral Valve Disease: A Comparative Study With Histopathology. Korean Circ J. 2012;42(5):311.
13. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation: Analysis and Implications. Arch Intern Med. 1995;155(5):469‑73.
14. Horstkotte D. Arrhythmias in the natural history of mitral stenosis. Acta Cardiol. 1992;47(2):105‑13.
15. Probst P, Goldschlager N, Selzer A. Left atrial size and atrial fibrillation in mitral stenosis. Factors influencing their relationship. Circulation. 1973;48(6):1282‑7.
16. Wood P. An Appreciation of Mitral Stenosis—II. Br Med J. 1954;1(4871):1113‑24.
17. Selzer A, Katayama F. Mitral regurgitation: clinical patterns, pathophysiology and natural history. Medicine (Baltimore). 1972 ;51(5) :337‑66.
18. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol Engl Ed. 2022;75(6):524